Back to Journals » ImmunoTargets and Therapy » Volume 4

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Total article views   HTML views PDF downloads Totals
12,177 Dovepress* 9,421+ 1,888 11,309
PubMed Central* 2,756 407 3,163
Totals 12,177 2,295 14,472
*Since 7 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar